DeepMed Research

Rogel Cancer Center: University of Michigan

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1991-01-01

Employees: -

Market Cap: -

Website: http://www.rogelcancercenter.org

Clinical Trials

MRI Study of Changes in Blood-Brain/Tumor-Barrier Permeability in Patients With Brain Metastases During and After Radiotherapy

Completed

Conditions: Brain Metastases

Interventions: Radiation: Fractionated Whole Brain Radiation Therapy (WBRT)
Radiation: Fractionated Stereotactic Radiation Therapy (FSRT)
Radiation: Single Fraction Stereotactic Radiosurgery (SRS)
Device: Magnetic Resonance Imaging (MRI) Assessments

First Posted Date: 2014-01-09

Last Posted Date: 2019-07-26

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 52

Registration Number: NCT02031237

Locations: 🇺🇸
University of Michigan Hospital, Ann Arbor, Michigan, United States

Randomized Phase II Study of DCE-MRI-based Dose Escalation for Poor-prognosis and Neck Cancer

Phase 2

Active, not recruiting

Conditions: Squamous Cell Carcinoma of the Head and Neck

Interventions: Drug: Cisplatin
Drug: Carboplatin
Radiation: IMRT (Intensity-Modulated Radiation Therapy)
Radiation: Boost Radiation to Hypoperfused Volumes

First Posted Date: 2014-01-09

Last Posted Date: 2023-08-31

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 106

Registration Number: NCT02031250

Locations: 🇺🇸
University of Michigan Hospital, Ann Arbor, Michigan, United States
🇺🇸
Veterans Affairs (VA) Ann Arbor Healthcare System, Ann Arbor, Michigan, United States

A Phase II Trial of Proton Pump Inhibitors With Chemotherapy in Patients With Metastatic Head and Neck Cancer

Phase 2

Withdrawn

Conditions: Cancer of Head and Neck

Interventions: Drug: Omeprazole
Drug: Carboplatin
Drug: 5FU
Drug: Paclitaxel
Drug: Pemetrexed

First Posted Date: 2013-12-17

Last Posted Date: 2014-12-02

Lead Sponsor: University of Michigan Rogel Cancer Center

Registration Number: NCT02013453

Locations: 🇺🇸
University of Michigan Hospital, Ann Arbor, Michigan, United States

A Pilot Study to Evaluate Neurocognitive Injury and Longitudinal Changes in White Matter During Radiation Therapy in Children With Primary Brain Tumors

Not Applicable

Terminated

Conditions: Brain Tumor, Primary

Interventions: Radiation: Cranial Radiotherapy
Device: MRI with Diffusion Tensor Imaging (DTI)
Behavioral: Neuro-cognitive Testing (CogState)

First Posted Date: 2013-12-10

Last Posted Date: 2016-12-30

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 5

Registration Number: NCT02006407

Locations: 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States

MRI Study of Radiation-Induced Damage to White Matter and Blood-Brain-Barrier

Completed

Conditions: Brain Neoplasms

Interventions: Radiation: Partial Brain Irradiation
Radiation: Whole Brain Irradiation
Behavioral: Neuropsychological Testing
Behavioral: Quality of Life Questionnaire
Device: Magnetic Resonance Imaging (MRI) Assessments

First Posted Date: 2013-11-20

Last Posted Date: 2018-06-06

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 91

Registration Number: NCT01988675

Locations: 🇺🇸
University of Michigan Hosptial, Ann Arbor, Michigan, United States

A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic Cancer

Completed

Conditions: Pancreatic Cancer

Interventions: Radiation: Standard Radiation Therapy
Device: Active Breathing Control Device (ABC)
Device: Computed Tomography Scan (CT)

First Posted Date: 2013-11-18

Last Posted Date: 2017-03-03

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 9

Registration Number: NCT01986738

Locations: 🇺🇸
University of Michigan Cancer Center, Ann Arbor, Michigan, United States

Pilot Study of Bone Biopsy and Aspirate in Women With Metastatic Breast Cancer

Terminated

Conditions: Metastatic Breast Cancer

Interventions: Procedure: Bone marrow aspirates and biopsy

First Posted Date: 2013-11-03

Last Posted Date: 2023-09-01

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 8

Registration Number: NCT01975597

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States

Mechanistic Study of Duloxetine in Breast Cancer Patients With Chronic Pain

Phase 2

Completed

Conditions: Pain

Interventions: Drug: Duloxetine

First Posted Date: 2013-07-31

Last Posted Date: 2020-08-06

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 82

Registration Number: NCT01912612

Locations: 🇺🇸
University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States
🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer

Completed

Conditions: Arthralgia
Obesity
Breast Cancer

Interventions: Drug: anastrozole, letrozole, exemestane
Drug: Tamoxifen

First Posted Date: 2013-07-11

Last Posted Date: 2016-06-28

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 115

Registration Number: NCT01896050

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

Pilot Study to Evaluate the Effect of Aromatase Inhibitor Therapy on Pain Threshold in Breast Cancer Patients

Completed

Conditions: Arthralgia
Breast Cancer
Pain

Interventions: Drug: Anastrozole
Drug: exemestane
Drug: letrozole

First Posted Date: 2013-03-19

Last Posted Date: 2024-02-07

Lead Sponsor: University of Michigan Rogel Cancer Center

Target Recruit Count: 50

Registration Number: NCT01814397

Locations: 🇺🇸
University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy